How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis

Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine v...

Full description

Saved in:
Bibliographic Details
Published inJournal of the International AIDS Society Vol. 26; no. 11; pp. e26189 - n/a
Main Authors Roberts, Sarah T., Mancuso, Noah, Williams, Kristin, Nabunya, Hadijah Kalule, Mposula, Hlengiwe, Mugocha, Caroline, Mvinjelwa, Priscilla, Garcia, Morgan, Szydlo, Daniel W., Soto‐Torres, Lydia, Ngure, Kenneth, Hosek, Sybil
Format Journal Article
LanguageEnglish
Published Switzerland John Wiley & Sons, Inc 01.11.2023
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
AbstractList Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.INTRODUCTIONEffective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16-21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, "peer buddies" and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants' experiences with adherence support and how it encouraged product use.METHODSREACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16-21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, "peer buddies" and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants' experiences with adherence support and how it encouraged product use.Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%-68% received results showing high adherence for oral PrEP, and 73%-89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF.RESULTSParticipants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%-68% received results showing high adherence for oral PrEP, and 73%-89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF.Implementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.CONCLUSIONSImplementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Introduction: Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods: REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results: Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions: Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
IntroductionEffective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.MethodsREACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use.ResultsParticipants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF.ConclusionsImplementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16-21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, "peer buddies" and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants' experiences with adherence support and how it encouraged product use. Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%-68% received results showing high adherence for oral PrEP, and 73%-89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF. Implementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs ( n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.
Audience Academic
Author Nabunya, Hadijah Kalule
Mvinjelwa, Priscilla
Roberts, Sarah T.
Soto‐Torres, Lydia
Mancuso, Noah
Mposula, Hlengiwe
Ngure, Kenneth
Williams, Kristin
Hosek, Sybil
Szydlo, Daniel W.
Mugocha, Caroline
Garcia, Morgan
Author_xml – sequence: 1
  givenname: Sarah T.
  orcidid: 0000-0002-3318-9781
  surname: Roberts
  fullname: Roberts, Sarah T.
  email: sroberts@rti.org
  organization: Women's Global Health Imperative, RTI International
– sequence: 2
  givenname: Noah
  orcidid: 0000-0002-4442-9293
  surname: Mancuso
  fullname: Mancuso, Noah
  organization: Women's Global Health Imperative, RTI International
– sequence: 3
  givenname: Kristin
  surname: Williams
  fullname: Williams, Kristin
  organization: RTI International
– sequence: 4
  givenname: Hadijah Kalule
  surname: Nabunya
  fullname: Nabunya, Hadijah Kalule
  organization: Makerere University‐Johns Hopkins University Research Collaboration
– sequence: 5
  givenname: Hlengiwe
  surname: Mposula
  fullname: Mposula, Hlengiwe
  organization: Wits Reproductive Health and HIV Institute
– sequence: 6
  givenname: Caroline
  surname: Mugocha
  fullname: Mugocha, Caroline
  organization: University of Zimbabwe Clinical Trials Research Centre
– sequence: 7
  givenname: Priscilla
  surname: Mvinjelwa
  fullname: Mvinjelwa, Priscilla
  organization: Desmond Tutu HIV Centre
– sequence: 8
  givenname: Morgan
  surname: Garcia
  fullname: Garcia, Morgan
  organization: FHI 360
– sequence: 9
  givenname: Daniel W.
  surname: Szydlo
  fullname: Szydlo, Daniel W.
  organization: Fred Hutchinson Cancer Center
– sequence: 10
  givenname: Lydia
  surname: Soto‐Torres
  fullname: Soto‐Torres, Lydia
  organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 11
  givenname: Kenneth
  orcidid: 0000-0002-8062-0933
  surname: Ngure
  fullname: Ngure, Kenneth
  organization: University of Washington
– sequence: 12
  givenname: Sybil
  surname: Hosek
  fullname: Hosek, Sybil
  organization: University of Illinois Chicago
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37936551$$D View this record in MEDLINE/PubMed
BookMark eNp9kt2O1CAUxxuzxv3QGx_AkJgYYzIj0BaKd5ONOmM28cKP24bCacukhRFax7nzEXwdX8cnke6s66yZGC6Aw-_8Dxz-58mJdRaS5DHBc4Ixfbk2ks4pI4W4l5wRnhczynJ6crA-Tc5DWGPMaJGJB8lpykXK8pycJT-Xbosk6sGOyNVI6hY8WAUojJuN8wMKg5cDNAYCqqUynRniVqPWNO0BPTi0XH1GGw9fwQ7G2bh0elRDQLJ3tomo6yCoeIga47sYthrt3BiPti5WR8bGktWv7z8-yFZ6adGi9kbJV9PlzLdYsYehdXpKlN0umPAwuV_LLsCjm_ki-fTm9cfL5ezq_dvV5eJqpnKRi5nmeYZ5lSuWca5pqllViCKXWHKBa6ZTICkH0KkktKp4ptO6YjyjDHNeAcnSi2S119VOrsuNN730u9JJU14HnG9K6QejOigLUmWpUlmKqzTDmBeUElUAk4UQtQYctZ7vtWJ3vowQhrI3sSldJy24MZS0KHjGc05ERJ_-g67d6OPbJ0pkhPE8Lf5SjYz1ja1d_C41iZYLLghmWFAWqdkRqgELXnbRS7WJ4Tv8_Agfh4beqKMJzw4SWpDd0AbXjZMTwl3wxR5U3oXgob5tKMHlZOZyMnN5beYIP7lpwVj1oG_RP-6NANkD23if3X-kynerBd2L_gbMLv_f
CitedBy_id crossref_primary_10_1002_jia2_26213
crossref_primary_10_1002_jia2_26217
crossref_primary_10_1002_jia2_26255
crossref_primary_10_1097_MOP_0000000000001357
Cites_doi 10.1007/s10461-016-1609-1
10.1007/s10461-021-03391-w
10.1186/s12879-018-3463-4
10.1186/s12913-018-3623-7
10.1007/s10461-021-03231-x
10.1007/s10461-018-02387-3
10.1007/s10461-018-2371-3
10.1186/s12978-021-01183-y
10.1097/QAD.0000000000001145
10.1371/journal.pmed.1003670
10.1089/aid.2012.0089
10.1056/NEJMoa1602046
10.1002/jia2.25909
10.1080/09540121.2018.1515471
10.1016/S0140-6736(07)60371-7
10.1371/journal.pone.0258542
10.1111/hiv.12132
10.7448/IAS.19.7.21107
10.1097/QAD.0000000000000647
10.1128/AAC.01710-17
10.1097/COH.0b013e3283590632
10.1001/jama.2019.2591
10.1007/s10461-018-2095-4
10.1186/s12889-021-11335-1
10.1002/jia2.25636
10.1007/s10461-020-03026-6
10.1016/j.jpba.2016.03.023
10.1080/16549716.2018.1536412
10.1097/QAI.0000000000001830
10.1371/journal.pone.0189770
10.1016/S0140-6736(11)60878-7
10.1097/QAI.0b013e3182801081
10.1002/jia2.25962
10.1097/QAD.0000000000002777
10.1097/QAD.0000000000001868
10.1002/jia2.25634
10.1002/jia2.25298
10.1016/S1473-3099(14)70847-3
10.1007/s10461-022-03663-z
10.1007/s11904-019-00431-y
10.2147/IJWH.S185712
10.1080/15381501.2013.773575
10.1089/apc.2013.0085
10.1371/journal.pmed.1004097
10.1007/s10461-021-03286-w
10.1007/s10461-022-03588-7
10.2337/dc13-0816
10.1097/QAI.0000000000001179
10.1016/S2352-3018(20)30307-6
10.1002/jia2.25463
10.1089/apc.2014.0273
10.1056/NEJMoa1506110
10.1097/QAD.0000000000003500
10.1007/s10461-018-2034-4
10.1097/JNC.0000000000000350
10.1016/j.jadohealth.2012.12.014
10.1037/0033-2909.111.3.455
10.1007/s10461-016-1650-0
10.1177/1558689810382916
10.1007/s10508-020-01880-y
10.1016/j.jadohealth.2016.03.014
10.1016/S0005-7967(00)00091-7
10.1007/BF02506983
10.1177/1359105311398727
10.1016/S2352-3018(20)30304-0
10.1097/QAD.0000000000001452
10.1007/s10461-023-04109-w
10.1016/S2352-4642(20)30248-0
10.1016/S2352-3018(23)00227-8
10.1002/jia2.26069
10.1371/journal.pone.0287525
10.1093/cid/ciy810
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Ltd on behalf of International AIDS Society.
2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
COPYRIGHT 2023 John Wiley & Sons, Inc.
2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Ltd on behalf of International AIDS Society.
– notice: 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
– notice: COPYRIGHT 2023 John Wiley & Sons, Inc.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1002/jia2.26189
DatabaseName Wiley Online Library Open Access
Wiley Online Library Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Publicly Available Content Database
MEDLINE
CrossRef




Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1758-2652
EndPage n/a
ExternalDocumentID oai_doaj_org_article_81b43cc430b340078221c8e6a899fde0
A791060926
10_1002_jia2_26189
37936551
JIA226189
Genre article
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations South Africa
Zimbabwe
Sub-Saharan Africa
Uganda
Kenya
Africa
GeographicLocations_xml – name: South Africa
– name: Zimbabwe
– name: Sub-Saharan Africa
– name: Uganda
– name: Kenya
– name: Africa
GrantInformation_xml – fundername: National Institute of Allergy and Infectious Diseases
  funderid: UM1AI068615; UM1AI068633; UM1AI106707
– fundername: National Institute of Mental Health
– fundername: Eunice Kennedy Shriver National Institute of Child Health and Human Development
– fundername: NIAID NIH HHS
  grantid: UM1 AI068615
– fundername: NIAID NIH HHS
  grantid: UM1 AI069463
– fundername: NIAID NIH HHS
  grantid: U01 AI068633
– fundername: NIAID NIH HHS
  grantid: U01 AI069463
– fundername: NIMH NIH HHS
– fundername: NIAID NIH HHS
  grantid: UM1 AI106707
GroupedDBID ---
-5E
-5G
-BR
0R~
1OC
24P
29L
2VQ
2WC
3V.
4.4
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAHHS
ABDBF
ABUWG
ACCFJ
ACGFO
ACGFS
ACRMQ
ACXQS
ADBBV
ADINQ
ADKYN
ADPDF
ADRAZ
ADUKV
ADZMN
AEEZP
AEGXH
AENEX
AEQDE
AFGXO
AFKRA
AHBYD
AHMBA
AIAGR
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMKLP
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
DIK
E3Z
EBD
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICW
IEA
IHR
IHW
INH
INR
IOF
ITC
KQ8
M1P
M48
M~E
N8Y
O5R
O5S
O9-
OK1
OVD
OVEED
P2P
PIMPY
PQQKQ
PROAC
PSQYO
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TEORI
TR2
TUS
UKHRP
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c5959-d75407b5c6477d23d6b8985a0a790f6d3e137eed3a12bb74d3fb67426077be143
IEDL.DBID COVID
ISSN 1758-2652
IngestDate Tue Oct 22 15:16:45 EDT 2024
Wed Oct 16 16:45:24 EDT 2024
Thu Oct 10 22:49:54 EDT 2024
Thu Jun 13 23:58:07 EDT 2024
Tue Oct 22 21:18:00 EDT 2024
Tue Jun 04 11:53:00 EDT 2024
Tue Aug 20 22:14:30 EDT 2024
Thu Sep 12 16:53:46 EDT 2024
Wed Oct 23 09:54:28 EDT 2024
Sat Aug 24 01:00:21 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords pre-exposure prophylaxis
sub-Saharan Africa
HIV
adolescents
medication adherence
psychosocial intervention
female
Language English
License Attribution
2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5959-d75407b5c6477d23d6b8985a0a790f6d3e137eed3a12bb74d3fb67426077be143
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-4442-9293
0000-0002-8062-0933
0000-0002-3318-9781
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.proquest.com/docview/2894167538?pq-origsite=%requestingapplication%
PMID 37936551
PQID 2894167538
PQPubID 55048
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_81b43cc430b340078221c8e6a899fde0
proquest_miscellaneous_2887475719
proquest_journals_2894167538
gale_infotracmisc_A791060926
gale_infotracgeneralonefile_A791060926
gale_infotracacademiconefile_A791060926
gale_healthsolutions_A791060926
crossref_primary_10_1002_jia2_26189
pubmed_primary_37936551
wiley_primary_10_1002_jia2_26189_JIA226189
PublicationCentury 2000
PublicationDate November 2023
2023-11-00
20231101
2023-11-01
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: November 2023
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Geneva
PublicationTitle Journal of the International AIDS Society
PublicationTitleAlternate J Int AIDS Soc
PublicationYear 2023
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References 2021; 25
2013; 29
2021; 21
2023; 37
2019; 11
2013; 62
2019; 16
2016; 30
2022; 25
2022; 26
2014; 28
2011; 16
2019; 321
2021; 35
2017; 31
2017; 74
2020; 4
2019; 22
2023; 26
2013; 12
1992; 111
2019; 68
1995; 23
2019; 23
2013; 52
2014; 15
2014; 14
2018; 30
2022; 33
2018; 32
2010; 4
2018; 79
2021; 8
2011; 378
2007; 369
2016; 19
2012
2023; 18
2017; 21
2018; 62
2016; 125
2002
2021; 50
2018; 22
2016; 59
1999
2018; 18
2021; 16
2015; 29
2023
2022
2021
2021; 18
2014; 37
2019
2018
2016; 375
2017
2016
2020; 23
2015
2001; 39
2012; 7
2018; 11
2022; 19
2018; 13
e_1_2_12_4_1
e_1_2_12_6_1
e_1_2_12_19_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_38_1
e_1_2_12_20_1
e_1_2_12_41_1
e_1_2_12_66_1
e_1_2_12_22_1
e_1_2_12_43_1
e_1_2_12_64_1
e_1_2_12_85_1
e_1_2_12_24_1
e_1_2_12_45_1
e_1_2_12_26_1
e_1_2_12_47_1
e_1_2_12_62_1
e_1_2_12_83_1
e_1_2_12_60_1
e_1_2_12_81_1
e_1_2_12_28_1
e_1_2_12_49_1
e_1_2_12_31_1
e_1_2_12_52_1
e_1_2_12_77_1
e_1_2_12_33_1
e_1_2_12_54_1
e_1_2_12_75_1
e_1_2_12_35_1
e_1_2_12_56_1
e_1_2_12_37_1
e_1_2_12_58_1
e_1_2_12_79_1
e_1_2_12_14_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_10_1
e_1_2_12_73_1
e_1_2_12_50_1
e_1_2_12_71_1
e_1_2_12_3_1
e_1_2_12_5_1
e_1_2_12_18_1
e_1_2_12_16_1
e_1_2_12_39_1
e_1_2_12_42_1
e_1_2_12_65_1
e_1_2_12_21_1
e_1_2_12_44_1
e_1_2_12_63_1
e_1_2_12_86_1
e_1_2_12_23_1
e_1_2_12_46_1
e_1_2_12_69_1
e_1_2_12_25_1
e_1_2_12_48_1
e_1_2_12_67_1
e_1_2_12_80_1
e_1_2_12_61_1
e_1_2_12_84_1
e_1_2_12_40_1
e_1_2_12_82_1
e_1_2_12_27_1
e_1_2_12_29_1
Steiberg L (e_1_2_12_68_1) 1999
e_1_2_12_30_1
e_1_2_12_53_1
e_1_2_12_76_1
e_1_2_12_32_1
e_1_2_12_55_1
e_1_2_12_74_1
e_1_2_12_34_1
e_1_2_12_57_1
e_1_2_12_36_1
e_1_2_12_59_1
e_1_2_12_78_1
e_1_2_12_15_1
e_1_2_12_13_1
e_1_2_12_11_1
e_1_2_12_72_1
e_1_2_12_7_1
e_1_2_12_51_1
e_1_2_12_70_1
e_1_2_12_9_1
References_xml – volume: 39
  start-page: 1151
  issue: 10
  year: 2001
  end-page: 1162
  article-title: Two strategies to increase adherence to HIV antiretroviral medication: life‐steps and medication monitoring
  publication-title: Behav Res Ther
– volume: 74
  start-page: 21
  issue: 1
  year: 2017
  end-page: 29
  article-title: An HIV preexposure prophylaxis demonstration project and safety study for young MSM
  publication-title: J Acquir Immune Defic Syndr
– volume: 25
  issue: 7
  year: 2022
  article-title: PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project
  publication-title: J Int AIDS Soc
– volume: 321
  start-page: 2214
  issue: 22
  year: 2019
  end-page: 2230
  article-title: Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force
  publication-title: JAMA
– volume: 37
  start-page: 977
  issue: 6
  year: 2023
  end-page: 986
  article-title: Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa
  publication-title: AIDS
– volume: 8
  start-page: e130
  issue: 3
  year: 2021
  end-page: e137
  article-title: Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial
  publication-title: Lancet HIV
– volume: 16
  start-page: 1071
  issue: 7
  year: 2011
  end-page: 1081
  article-title: A situated‐Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB‐CIM): an IMB model based approach to understanding and intervening in engagement in care for chronic medical conditions
  publication-title: J Health Psychol
– volume: 14
  start-page: 820
  issue: 9
  year: 2014
  end-page: 829
  article-title: Uptake of pre‐exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
  publication-title: Lancet Infect Dis
– volume: 26
  issue: 3
  year: 2023
  article-title: Uptake and continuation of HIV pre‐exposure prophylaxis among women of reproductive age in two health facilities in Kisumu County, Kenya
  publication-title: J Int AIDS Soc.
– year: 2021
– volume: 26
  start-page: 375
  issue: 2
  year: 2022
  end-page: 384
  article-title: HIV prevention and treatment behavior change and the situated Information Motivation Behavioral Skills (sIMB) model: a qualitative evaluation of a community health worker intervention in Rakai, Uganda
  publication-title: AIDS Behav.
– volume: 26
  start-page: 2494
  issue: 7
  year: 2022
  end-page: 2502
  article-title: Assessing the information‐motivation‐behavioral skills model to predict pre‐exposure prophylaxis adherence among black men who have sex with men and transgender women in a community setting in New York City
  publication-title: AIDS Behav
– volume: 50
  start-page: 1729
  issue: 4
  year: 2021
  end-page: 1742
  article-title: Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa
  publication-title: Arch Sex Behav
– volume: 29
  start-page: 1277
  issue: 11
  year: 2015
  end-page: 1285
  article-title: Defining success with HIV pre‐exposure prophylaxis: a prevention‐effective adherence paradigm
  publication-title: AIDS
– year: 2021
  article-title: Adherence to the dapivirine vaginal ring and oral PrEP among adolescent girls and young women in Africa: interim results from the REACH study
– volume: 32
  start-page: 1517
  issue: 11
  year: 2018
  end-page: 1525
  article-title: Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug‐level results
  publication-title: AIDS
– volume: 79
  start-page: 458
  issue: 4
  year: 2018
  end-page: 466
  article-title: Comparing youth‐friendly health services to the standard of care through “Girl Power‐Malawi”: a quasi‐experimental cohort study
  publication-title: J Acquir Immune Defic Syndr
– year: 2018
– volume: 22
  year: 2019
  article-title: HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
  publication-title: J Int AIDS Soc
– volume: 375
  start-page: 2133
  issue: 22
  year: 2016
  end-page: 2143
  article-title: Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women
  publication-title: N Engl J Med
– volume: 25
  start-page: 721
  issue: 3
  year: 2021
  end-page: 731
  article-title: Sharing objective measures of adherence to a vaginal microbicide promotes candor about actual use and bolsters motivation to prevent HIV
  publication-title: AIDS Behav
– volume: 13
  issue: 1
  year: 2018
  article-title: Interventions to improve antiretroviral therapy adherence among adolescents in low‐ and middle‐income countries: a systematic review of the literature
  publication-title: PLoS One
– volume: 21
  start-page: 1299
  issue: 5
  year: 2017
  end-page: 1308
  article-title: Willingness to use pre‐exposure prophylaxis (PrEP): an empirical test of the Information‐Motivation‐Behavioral Skills (IMB) model among high‐risk drug users in treatment
  publication-title: AIDS Behav
– volume: 23
  start-page: 2185
  issue: 8
  year: 2019
  end-page: 2189
  article-title: Debrief reports to expedite the impact of qualitative research: do they accurately capture data from in‐depth interviews?
  publication-title: AIDS Behav
– volume: 23
  issue: 11
  year: 2020
  article-title: Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial
  publication-title: J Int AIDS Soc
– volume: 16
  issue: 10
  year: 2021
  article-title: Adolescent girls and young women's PrEP‐user journey during an implementation science study in South Africa and Kenya
  publication-title: PLoS One
– volume: 125
  start-page: 94
  year: 2016
  end-page: 100
  article-title: Post‐use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence
  publication-title: J Pharm Biomed Anal
– year: 2022
  article-title: Evaluating adaptive HIV pre‐exposure prophylaxis adherence interventions for young South African women: results from a sequential multiple assignment randomized trial
– volume: 18
  start-page: 581
  issue: 1
  year: 2018
  article-title: A systematic review of adherence to oral pre‐exposure prophylaxis for HIV—how can we improve uptake and adherence?
  publication-title: BMC Infect Dis
– volume: 25
  issue: 5
  year: 2022
  article-title: Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study
  publication-title: J Int AIDS Soc
– volume: 31
  start-page: 1159
  issue: 8
  year: 2017
  end-page: 1167
  article-title: Acceptability and use of a dapivirine vaginal ring in a phase III trial
  publication-title: AIDS
– volume: 4
  start-page: 875
  issue: 12
  year: 2020
  end-page: 883
  article-title: Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre‐exposure prophylaxis in South African adolescents: an open‐label single‐arm phase 2 trial
  publication-title: Lancet Child Adolesc Health
– year: 2018
  article-title: Empowerment clubs did not increase PrEP continuation among adolescent girls and young women in South Africa and Tanzania—results from the EMPOWER randomised trial
– volume: 22
  start-page: 2650
  issue: 8
  year: 2018
  end-page: 2661
  article-title: Project ACCEPT: evaluation of a group‐based intervention to improve engagement in care for youth newly diagnosed with HIV
  publication-title: AIDS Behav
– volume: 19
  issue: 7
  year: 2016
  article-title: Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
  publication-title: J Int AIDS Soc
– volume: 11
  start-page: 97
  year: 2019
  end-page: 107
  article-title: We are not the same”: African women's view of multipurpose prevention products in the TRIO clinical study
  publication-title: Int J Women's Health
– volume: 18
  issue: 6
  year: 2023
  article-title: Baseline preferences for oral pre‐exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe
  publication-title: PLoS One
– volume: 23
  issue: 11
  year: 2020
  article-title: Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial
  publication-title: J Int AIDS Soc
– volume: 369
  start-page: 1565
  issue: 9572
  year: 2007
  end-page: 1573
  article-title: Youth‐friendly primary‐care services: how are we doing and what more needs to be done?
  publication-title: Lancet
– volume: 21
  start-page: 481
  issue: 2
  year: 2017
  end-page: 491
  article-title: Misreporting of product adherence in the MTN‐003/VOICE trial for HIV prevention in Africa: participants' explanations for dishonesty
  publication-title: AIDS Behav
– year: 2023
  article-title: Adolescent girls and young women's experiences with disclosing oral PrEP or dapivirine vaginal ring use: a multi‐country qualitative analysis
  publication-title: AIDS Behav
– volume: 8
  start-page: e87
  issue: 2
  year: 2021
  end-page: e95
  article-title: Safety, uptake, and use of a dapivirine vaginal ring for HIV‐1 prevention in African women (HOPE): an open‐label, extension study
  publication-title: Lancet HIV
– volume: 16
  start-page: 120
  issue: 1
  year: 2019
  end-page: 128
  article-title: HIV prevention interventions for adolescents
  publication-title: Curr HIV/AIDS Rep
– volume: 19
  issue: 9
  year: 2022
  article-title: Continued attendance in a PrEP program despite low adherence and non‐protective drug levels among adolescent girls and young women in Kenya: results from a prospective cohort study
  publication-title: PLoS Med
– volume: 23
  issue: 3
  year: 2020
  article-title: The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study
  publication-title: J Int AIDS Soc
– year: 2019
– volume: 18
  start-page: 135
  issue: 1
  year: 2021
  article-title: Factors influencing access to and utilisation of youth‐friendly sexual and reproductive health services in sub‐Saharan Africa: a systematic review
  publication-title: Reprod Health
– year: 2015
– volume: 30
  start-page: 1973
  issue: 12
  year: 2016
  end-page: 1983
  article-title: Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
  publication-title: AIDS
– volume: 22
  start-page: 3603
  issue: 11
  year: 2018
  end-page: 3616
  article-title: An information‐motivation‐behavioral skills model of PrEP uptake
  publication-title: AIDS Behav
– volume: 15
  start-page: 385
  issue: 7
  year: 2014
  end-page: 395
  article-title: Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions
  publication-title: HIV Med
– volume: 68
  start-page: 2010
  issue: 12
  year: 2019
  end-page: 2017
  article-title: Randomized controlled trial of a mobile health intervention to promote retention and adherence to preexposure prophylaxis among young people at risk for human immunodeficiency virus: the EPIC study
  publication-title: Clin Infect Dis
– volume: 26
  start-page: 3607
  issue: 11
  year: 2022
  end-page: 3619
  article-title: Women's experience receiving drug feedback and adherence counseling in MTN‐025/HOPE—an HIV prevention open‐label trial of the dapivirine vaginal ring
  publication-title: AIDS Behav
– volume: 111
  start-page: 455
  issue: 3
  year: 1992
  end-page: 474
  article-title: Changing AIDS‐risk behavior
  publication-title: Psychol Bull
– volume: 33
  start-page: 534
  issue: 5
  year: 2022
  end-page: 541
  article-title: Mystery shopper assessment of PrEP service delivery quality for adolescent girls and young women in Kenya: a cross‐sectional study
  publication-title: J Assoc Nurses AIDS Care
– volume: 7
  start-page: 534
  issue: 6
  year: 2012
  end-page: 541
  article-title: Acceptability in microbicide and PrEP trials: current status and a reconceptualization
  publication-title: Curr Opin HIV AIDS
– volume: 29
  start-page: 193
  issue: 4
  year: 2015
  end-page: 203
  article-title: Clinician attitudes toward CDC interim pre‐exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents
  publication-title: AIDS Patient Care STDs
– volume: 11
  issue: 1
  year: 2018
  article-title: A systematic review of the use of adolescent mystery clients in assessing the adolescent friendliness of health services in high, middle, and low‐income countries
  publication-title: Glob Health Action
– volume: 18
  start-page: 809
  issue: 1
  year: 2018
  article-title: Assessment of adolescent and youth friendly services in primary healthcare facilities in two provinces in South Africa
  publication-title: BMC Health Serv Res
– volume: 21
  start-page: 1284
  issue: 1
  year: 2021
  article-title: Facilitators and barriers to HIV pre‐exposure prophylaxis (PrEP) uptake through a community‐based intervention strategy among adolescent girls and young women in Seme Sub‐County, Kisumu, Kenya
  publication-title: BMC Public Health
– volume: 25
  start-page: 4169
  issue: 12
  year: 2021
  end-page: 4179
  article-title: The influence of perceived dapivirine vaginal ring effectiveness on social disclosure and ring adherence
  publication-title: AIDS Behav
– volume: 28
  start-page: 33
  issue: 1
  year: 2014
  end-page: 42
  article-title: EVOLUTION–taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV
  publication-title: AIDS Patient Care STDs
– volume: 37
  start-page: 625
  issue: 3
  year: 2014
  end-page: 633
  article-title: A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT‐AD) in patients with uncontrolled type 2 diabetes
  publication-title: Diabetes Care
– year: 2023
  article-title: Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre‐exposure prophylaxis among African adolescent girls and young women: a randomised, open‐label, crossover trial
  publication-title: Lancet HIV
– volume: 23
  start-page: 1904
  issue: 7
  year: 2019
  end-page: 1916
  article-title: Applying the information‐motivation‐behavioral skills model to understand PrEP intentions and use among men who have sex with men
  publication-title: AIDS Behav
– year: 2016
– volume: 25
  start-page: 2801
  issue: 9
  year: 2021
  end-page: 2814
  article-title: Correlates of adherence to the dapivirine vaginal ring for HIV‐1 prevention
  publication-title: AIDS Behav
– volume: 4
  start-page: 342
  issue: 4
  year: 2010
  end-page: 360
  article-title: A methodology for conducting integrative mixed methods research and data analyses
  publication-title: J Mix Methods Res
– year: 2012
– volume: 52
  start-page: 670
  issue: 6
  year: 2013
  end-page: 681
  article-title: Assessment of youth‐friendly health care: a systematic review of indicators drawn from young people's perspectives
  publication-title: J Adolesc Health
– volume: 23
  start-page: 581
  issue: 5
  year: 1995
  end-page: 599
  article-title: Psychological empowerment: issues and illustrations
  publication-title: Am J Community Psychol
– volume: 12
  start-page: 333
  issue: 3–4
  year: 2013
  end-page: 348
  article-title: Integrating behavioral HIV interventions into biomedical prevention trials with youth: lessons from Chicago's Project PrEPare
  publication-title: J HIV AIDS Soc Serv
– volume: 378
  start-page: 279
  issue: 9787
  year: 2011
  end-page: 281
  article-title: Drug concentrations after topical and oral antiretroviral pre‐exposure prophylaxis: implications for HIV prevention in women
  publication-title: Lancet
– volume: 59
  start-page: 7
  issue: 1
  year: 2016
  end-page: 16
  article-title: Sexually transmitted infection services for adolescents and youth in low‐ and middle‐income countries: perceived and experienced barriers to accessing care
  publication-title: J Adolesc Health
– year: 2002
– volume: 375
  start-page: 2121
  issue: 22
  year: 2016
  end-page: 2132
  article-title: Use of a vaginal ring containing dapivirine for HIV‐1 prevention in women
  publication-title: N Engl J Med
– volume: 29
  start-page: 384
  issue: 2
  year: 2013
  end-page: 390
  article-title: Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure
  publication-title: AIDS Res Hum Retroviruses
– volume: 62
  issue: 1
  year: 2018
  article-title: Intracellular tenofovir‐diphosphate and emtricitabine‐triphosphate in dried blood spots following directly observed therapy
  publication-title: Antimicrob Agents Chemother
– volume: 30
  start-page: S97
  issue: sup5
  year: 2018
  end-page: S105
  article-title: HIV care engagement and ART adherence among Kenyan gay, bisexual, and other men who have sex with men: a multi‐level model informed by qualitative research
  publication-title: AIDS Care
– year: 2017
– volume: 35
  start-page: 463
  issue: 3
  year: 2021
  end-page: 475
  article-title: Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre‐exposure prophylaxis services?
  publication-title: AIDS
– volume: 62
  start-page: 447
  issue: 4
  year: 2013
  end-page: 456
  article-title: The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men
  publication-title: J Acquir Immune Defic Syndr
– volume: 18
  issue: 6
  year: 2021
  article-title: PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: results from HPTN 082, a randomized controlled trial
  publication-title: PLoS Med
– year: 1999
– ident: e_1_2_12_22_1
  doi: 10.1007/s10461-016-1609-1
– ident: e_1_2_12_61_1
  doi: 10.1007/s10461-021-03391-w
– ident: e_1_2_12_7_1
  doi: 10.1186/s12879-018-3463-4
– ident: e_1_2_12_27_1
– ident: e_1_2_12_78_1
  doi: 10.1186/s12913-018-3623-7
– ident: e_1_2_12_17_1
  doi: 10.1007/s10461-021-03231-x
– ident: e_1_2_12_54_1
  doi: 10.1007/s10461-018-02387-3
– ident: e_1_2_12_74_1
– ident: e_1_2_12_58_1
  doi: 10.1007/s10461-018-2371-3
– ident: e_1_2_12_79_1
  doi: 10.1186/s12978-021-01183-y
– ident: e_1_2_12_3_1
  doi: 10.1097/QAD.0000000000001145
– ident: e_1_2_12_11_1
  doi: 10.1371/journal.pmed.1003670
– ident: e_1_2_12_42_1
  doi: 10.1089/aid.2012.0089
– ident: e_1_2_12_15_1
  doi: 10.1056/NEJMoa1602046
– ident: e_1_2_12_30_1
  doi: 10.1002/jia2.25909
– ident: e_1_2_12_57_1
  doi: 10.1080/09540121.2018.1515471
– ident: e_1_2_12_71_1
  doi: 10.1016/S0140-6736(07)60371-7
– ident: e_1_2_12_18_1
  doi: 10.1371/journal.pone.0258542
– ident: e_1_2_12_85_1
  doi: 10.1111/hiv.12132
– ident: e_1_2_12_63_1
  doi: 10.7448/IAS.19.7.21107
– ident: e_1_2_12_86_1
  doi: 10.1097/QAD.0000000000000647
– ident: e_1_2_12_43_1
  doi: 10.1128/AAC.01710-17
– ident: e_1_2_12_49_1
  doi: 10.1097/COH.0b013e3283590632
– ident: e_1_2_12_6_1
  doi: 10.1001/jama.2019.2591
– volume-title: Adolescence
  year: 1999
  ident: e_1_2_12_68_1
  contributor:
    fullname: Steiberg L
– ident: e_1_2_12_56_1
  doi: 10.1007/s10461-018-2095-4
– ident: e_1_2_12_21_1
  doi: 10.1186/s12889-021-11335-1
– ident: e_1_2_12_26_1
– ident: e_1_2_12_14_1
  doi: 10.1002/jia2.25636
– ident: e_1_2_12_45_1
  doi: 10.1007/s10461-020-03026-6
– ident: e_1_2_12_41_1
  doi: 10.1016/j.jpba.2016.03.023
– ident: e_1_2_12_80_1
  doi: 10.1080/16549716.2018.1536412
– ident: e_1_2_12_70_1
  doi: 10.1097/QAI.0000000000001830
– ident: e_1_2_12_4_1
– ident: e_1_2_12_84_1
  doi: 10.1371/journal.pone.0189770
– ident: e_1_2_12_9_1
  doi: 10.1016/S0140-6736(11)60878-7
– ident: e_1_2_12_65_1
  doi: 10.1097/QAI.0b013e3182801081
– ident: e_1_2_12_75_1
– ident: e_1_2_12_13_1
  doi: 10.1002/jia2.25962
– ident: e_1_2_12_83_1
  doi: 10.1097/QAD.0000000000002777
– ident: e_1_2_12_24_1
  doi: 10.1097/QAD.0000000000001868
– ident: e_1_2_12_5_1
  doi: 10.1002/jia2.25634
– ident: e_1_2_12_8_1
  doi: 10.1002/jia2.25298
– ident: e_1_2_12_44_1
  doi: 10.1016/S1473-3099(14)70847-3
– ident: e_1_2_12_53_1
  doi: 10.1007/s10461-022-03663-z
– ident: e_1_2_12_69_1
– ident: e_1_2_12_82_1
  doi: 10.1007/s11904-019-00431-y
– ident: e_1_2_12_2_1
– ident: e_1_2_12_51_1
  doi: 10.2147/IJWH.S185712
– ident: e_1_2_12_47_1
– ident: e_1_2_12_38_1
  doi: 10.1080/15381501.2013.773575
– ident: e_1_2_12_36_1
  doi: 10.1089/apc.2013.0085
– ident: e_1_2_12_12_1
  doi: 10.1371/journal.pmed.1004097
– ident: e_1_2_12_23_1
  doi: 10.1007/s10461-021-03286-w
– ident: e_1_2_12_59_1
  doi: 10.1007/s10461-022-03588-7
– ident: e_1_2_12_46_1
– ident: e_1_2_12_40_1
  doi: 10.2337/dc13-0816
– ident: e_1_2_12_67_1
  doi: 10.1097/QAI.0000000000001179
– ident: e_1_2_12_10_1
  doi: 10.1016/S2352-3018(20)30307-6
– ident: e_1_2_12_20_1
  doi: 10.1002/jia2.25463
– ident: e_1_2_12_64_1
  doi: 10.1089/apc.2014.0273
– ident: e_1_2_12_73_1
– ident: e_1_2_12_16_1
  doi: 10.1056/NEJMoa1506110
– ident: e_1_2_12_31_1
  doi: 10.1097/QAD.0000000000003500
– ident: e_1_2_12_37_1
  doi: 10.1007/s10461-018-2034-4
– ident: e_1_2_12_77_1
  doi: 10.1097/JNC.0000000000000350
– ident: e_1_2_12_76_1
– ident: e_1_2_12_72_1
  doi: 10.1016/j.jadohealth.2012.12.014
– ident: e_1_2_12_55_1
  doi: 10.1037/0033-2909.111.3.455
– ident: e_1_2_12_60_1
  doi: 10.1007/s10461-016-1650-0
– ident: e_1_2_12_48_1
  doi: 10.1177/1558689810382916
– ident: e_1_2_12_19_1
  doi: 10.1007/s10508-020-01880-y
– ident: e_1_2_12_81_1
  doi: 10.1016/j.jadohealth.2016.03.014
– ident: e_1_2_12_39_1
  doi: 10.1016/S0005-7967(00)00091-7
– ident: e_1_2_12_50_1
  doi: 10.1007/BF02506983
– ident: e_1_2_12_62_1
  doi: 10.1177/1359105311398727
– ident: e_1_2_12_29_1
  doi: 10.1016/S2352-3018(20)30304-0
– ident: e_1_2_12_52_1
  doi: 10.1097/QAD.0000000000001452
– ident: e_1_2_12_35_1
  doi: 10.1007/s10461-023-04109-w
– ident: e_1_2_12_66_1
  doi: 10.1016/S2352-4642(20)30248-0
– ident: e_1_2_12_28_1
  doi: 10.1016/S2352-3018(23)00227-8
– ident: e_1_2_12_32_1
  doi: 10.1002/jia2.26069
– ident: e_1_2_12_34_1
  doi: 10.1371/journal.pone.0287525
– ident: e_1_2_12_25_1
  doi: 10.1093/cid/ciy810
– ident: e_1_2_12_33_1
SSID ssj0062849
Score 2.42052
Snippet Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The...
Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial...
Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The...
Introduction: Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The...
Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial...
IntroductionEffective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The...
Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The...
SourceID doaj
proquest
gale
crossref
pubmed
wiley
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage e26189
SubjectTerms Acquired immune deficiency syndrome
Adolescent
Adolescents
AIDS
Anti-HIV Agents - therapeutic use
Counseling
Cross-Over Studies
Data collection
Disease prevention
Empowerment
Evaluation
Feedback
Female
Focus groups
Girls
Health aspects
HIV
HIV (Viruses)
HIV infection
HIV Infections - drug therapy
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Interpersonal relations
Medical care
medication adherence
Methods
Patient compliance
Pre-Exposure Prophylaxis - methods
Prevention
pre‐exposure prophylaxis
Prophylaxis
psychosocial intervention
Quality management
Sexually transmitted diseases
South Africa
sub‐Saharan Africa
Teenage girls
Young Adult
Young women
Zimbabwe
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtNADB6hPSEhxD-BBYxAICGVTeYnk3AriFV3JbjAor2NJjOT3SJIqm0r4MYj8Dq8Dk-CnUlDKhBcuOXHUVLbY39O48-MPcTFZwP9P6gkdxNpdTYpA-7WgvJFKmuXUb_zq9f57EgeHqvj0agv-iYs0gNHxe0hrJLCOSnSSsiY0DJXhNxioVD7EKv1TG2KqRiDcwy65UBGyvfezy1_irUCDXMfpZ-Opf_3WDxKRmPA2mWc_UvsYg8VYRof8TI7F5or7EJ8zwaxfegq-z5rP4GFj6FZQ1uD9aexfw-W6wVBa1iuNmQQUFsXObmDB6IpHkmvWpgdvINFT-jUNrCIVLBL6MYRwS_mJziZn33Aw42HLxQqoCNxgHmDt6x-fP32xhIHdANxAtEzerj5Z7xjnFVNF0YalGvsaP_l2xezST-OYeIUvSz0msj6KuWod9Vz4fOqKAtlU6vLtM69CJnQmHKFzXhVaelFXeWaGPC1rgLisutsp2mbcJNB6XihlNWFSoNMvSirjPMa0UMovEQMm7AHGyuZRWTdMJFfmRuypelsmbDnZMBBgpiyuwPoP6b3H_Mv_0nYPTK_iW2nw3o3U41AKk9LnifscSdBKx5N5mzfuIA_hbiztiQfbUmeRObwPwnubgniknbbpze-aPqQsjRYGSN4xuqySNj94TRdSZ_JNaFdk0yB5aHSGermRvThQTsCI3GO-DhhTzqn_otizeHBlHdbt_6Him-z8xyhYezg3GU7q7N1uINQblXd7VbtT439RN8
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9QwEA7n-UUQ8d3VU0cUBWHPNkmbVhBZxWPv4PyiK_ctpEm6rpztui9498v8e8403brF4771ZUrazEzmmbbzDGMv0PmMp--DieR2KI2Kh7nH3VJQvIhkaWOqdz7-nI4n8ugkOdlhm_6d7QQuL0ztqJ_UZHG6f_br_D06_LuWQPTNj5nh-5gJZPkVdpVLIcnSj2X3NSHFJTjvqEm35XvBqOHs_39l3gpN2_C1iT8HN9mNFjjCKGj6Ftvx1W12Pbx1g1BMdIf9Gde_wcBPX62hLsG476GaD5brOT0jLFcbaggojQ0M3d4BkRZvSa9qGB9-g3lL71RXMA_EsEtomhPBPx4omM4Wp3i4cnBOCwc0lA4wq3DIYvjFEB90BaEb0Vu6tdkZjhf6VtNlgRLlLpscfPr6cTxsWzMMbUIvDp0i4r4isVTH6rhwaZHlWWIio_KoTJ3wsVAYfoWJeVEo6URZpIrY8JUqPGK0e2y3qiv_gEFueZYkRmVJ5GXkRF7EnJeIJHzmJOLZAXu-0ZGeBwYOHbiWuSZN6kaTA_aB1NdJEGt2c6BeTHXrhBohuhTWShEVQgZwFNvMpwaTztJ5HOopKV-HEtTO9_VIIahKo5ynA_aqkSB7RIVZ0xYx4KMQj1ZP8mVPchpYxC8S3OsJonvb_umNJeqNd2jMkhFIY6aZDdiz7jRdSb_MVb5ek0yGqWKiYpyb-8GCu9kRuCqniJUH7HVj0pdMrD46HPFm6-Hld_KIXeMIAEOd5h7bXS3W_jECtlXxpPHGv1IkPUo
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ1bixMxFMfDur4IIt6trhpRFIS6M7lMZsSXKi7dBUXQlX0LuU2t6EzpBfXNj-DX8ev4STwnmc62KIJv7cwJ0-bknPyT9vxCyAMIPhPw90EpmBsKo_JhFeBtzXG-yETtcqx3fvW6GB-LoxN5skOerWthEh-i33DDyIj5GgPc2MX-KTT049SwJ6D_y-oMOQu6psQxzcSbdR4uIPFWsRxSwlgoJOvhpGz_tO3WdBSp_X_m5o3JaVPAxhno4CK50ElHOkq-vkR2QnOZnE_7bjSVE10hP8ftF2ro59CsaFtT4z-kej66WM1QatPFcg2HoLVxidEdPEVs8Yb1sqXjw_d01gGe2obOEhp2QePxRPSUBEUn0_knuNx4-g1TB41QBzpt4JH21_cfbw0yoRuaTiR6ih9u-hWemM6uxoYJi3KVHB-8fPdiPOyOZxg6iZuHXiG8z0qHtayecV_YsiqlyYyqsrrwPORcwRTMTc6sVcLz2hYKifhK2QA67RrZbdom3CC0cqyU0qhSZkFknlc2Z6wGNRFKL0DTDsj9tZf0LFE4dOItM42-1NGXA_IcHdhbIDk7XmjnE90FogaZLrhzgmeWiySQcleGwsDCs_YBHnUX3a9TGWof_3qkQFgVWcWKAXkULTADgMuc6QoZ4KsgS2vL8uGW5SSRxP9muLdlCCHutm-vx6LuUsxCw0oZxDSsNssBudffxpb4t7kmtCu0KWG5KFUOfXM9jeG-dzhk5gL08oA8joP6Hx2rjw5HLL66-T_Gt8g5BpIwVW7ukd3lfBVug4Rb2jsxUn8DANM_mA
  priority: 102
  providerName: Wiley-Blackwell
Title How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjia2.26189
https://www.ncbi.nlm.nih.gov/pubmed/37936551
https://www.proquest.com/docview/2894167538
https://www.proquest.com/docview/2887475719
https://doaj.org/article/81b43cc430b340078221c8e6a899fde0
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZY-4KEuF8KoxiBQEJKl9hJnPCCurGpm7QxAa2qvViO7ZRySUov4vLH-HucE6ddC2gPvKRtciI77vHnz47Pdwh5Cp1PWXw_GIVMe6ESgZda-JlzHC_8MNcBxjsfn8S9fng0jIb1gtus3la5xMQKqE2pcY18ByYGwB2AXCevJl89zBqFb1frFBpbpMkTmOk0SHPvzeDw9RKLYwDfdCVKynY-jhXrwJwBk7qvDUOVWv_fmLw2KK0T12rkObhG5LLObsPJp85innX0zz_kHP__oa6TqzUppV3nRTfIJVvcJFfcih51gUq3yK9e-Y0q-sUWC1rmVJkPLlKQzhYTJPF0Nl_KTtBcaaf-bQ1FQeQ163lJe4cDOqmlo8qCTpzo7IxWiY_oucYUHY2nn-F0YegPBCVayUXQcQFFZt47hVrTBXWZjl5i1cbfoTyXExtvc3Irt0n_YP_9Xs-r0z54OsJFSSNQFDCLNMbIGsZNnCVpEilfidTPY8NtwAUM7VwFLMtEaHiexQKV9oXILPC_O6RRlIW9R2iqWRJFSiSRb0Pf8DQLGMuBpdjEhMCVW-TJ0gvkxKl7SKfjzCT6iqx8pUV20UFWFqjIXZ0opyNZd3AJ9D_kWofcz3joiFegExsrmNDmxkJRj9C9pAtvXeGK7AogbLGfsrhFnlcWiCzwh2lVB0jAo6BG14blsw3LkVMo_5fh9oYhQIfevLx0S1lD10ye-2SLPF5dxjtxO15hywXaJDANjUQAbXPX9ZFV63BA_Bh4eIu8qDrNBQ0rjw67rPp2_-KaPCCXGZBLFwO6TRrz6cI-BDI4z9pki4WncBRD0SbN7qB_1ofP3f2T07ftGg3a1UILHI_D5Dd3EWal
link.rule.ids 315,786,790,870,2115,2236,11589,12083,21416,24346,27955,27956,31752,31753,33777,33778,38549,43343,43838,43928,46085,46509,50847,50956,74100,74657,74767
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagewAJcb8UBjMCgTQpXWInccILGoOpHdt4YJv2ZvmWUi5J6UVc_hh_j3PipGsB7YG3NjlRHOf4O58dn-8Q8hQGn3L4fTCJmQliJaIgd_C34BgvwrgwEeY7Hxym_eN47zQ5bRbcps22yhYTa6C2lcE18i2YGAB3AHKdvRx_DbBqFH5dbUpoXCRrEFhZ1iFrO-9OBq9bLE4BfPOFKCnb-jhSrAdzBizqvhSGarX-vzF5KSgtE9c68uxeI7Jts99w8qk3n-me-fmHnOP_P9R1crUhpXTbe9ENcsGVN8kVv6JHfaLSLfKrX32jin5x5ZxWBVX2g88UpNP5GEk8nc5a2QlaKOPVv52lKIi8ZD2raH9wQseNdFRV0rEXnZ3SuvARPdOYosPR5DMcLi39gaBEa7kIOirhljp4r1BruqS-0tELbNroO9zP18TGy7zcym1yvPvmaKcfNGUfApPgoqQVKAqoE4M5spZxm-oszxIVKpGHRWq5i7iA0M5VxLQWseWFTgUq7QuhHfC_O6RTVqW7R2huWJYkSmRJ6OLQ8lxHjBXAUlxmY-DKXfKk9QI59uoe0us4M4m-Imtf6ZJX6CALC1Tkrg9Uk6FsBrgE-h9zY2Ieah574hWZzKUKJrSFdXCrDXQv6dNbF7gitwUQtjTMWdolz2sLRBZ4YUY1CRLwKKjRtWL5bMVy6BXK_2W4vmII0GFWT7duKRvomsozn-ySx4vTeCVuxytdNUebDKahiYigb-76MbLoHQ6InwIP75LNetCc07Fyb7DN6l_3z2_JBrnUPzrYl_uDw7cPyGUGRNPng66Tzmwydw-BGM70o2b0_waPRWKn
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9QwEA56gggivrt6ehFFQajbJm3T-kXWl2X31EPQO_ZbSJN0XdG2bndRf5l_z5mk29tFuW99mZI2k5l5kmaeIeQxGJ-y-H8wiZkOYiWiILdwWnKMF2Fc6gjznT8cpZPj-HCWzLr9T223rXLjE52jNrXGNfIhTAwAOwC4zoZlty3i45vxy-ZHgBWk8E9rV07jPLkAUTLEMg5i1k--UnDDeU9PyoZfF4o9h9kDlnffCkiOt_9f77wVnrYhrItB46vkSgce6chr-xo5Z6vr5LJfeaM-oegG-TOpf1JFv9tqTeuSKvPFZ_TRdt0g2KbtakMPQUulPUu3NRSJi7ekVzWdTE9o01E81RVtPDlsS12BInrKBUXni-U3uFwZ-hudB3W0DnRRQZNF8EkhJ3RFfUWiF_hqi1_Qnq9djY95WpSb5Hj89vPrSdCVZwh0gouHRiB5X5FozGU1jJu0yPIsUaESeVimhtuICwjBXEWsKERseFmkAhnxhSgs4LRbZK-qK3uH0FyzLEmUyJLQxqHheRExVgKasJmJAdMOyKONjmTjWTik51tmEjUpnSYH5BWqr5dA5mx3oV7OZWeIEmB6zLWOeVjw2AOkSGc2VTDxLI2Fpg5Q-dKnofb2L0cCgFUa5iwdkKdOAj0AKEyrLpEBPgW5tHYkn-xIzj2T-P8E93cEwcT17u3NSJSdi2nlqUEMyMP-Nj6J2-YqW69RJoPpYiIi6JvbfgT3vcPBM6eAlwfkmRvSZ3SsPJyOmDu6e_abHJCLYJTy_fTo3T1yiQEe9Gmb-2RvtVzb-4DfVsUDZ5h_AeI_Qnc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+a+menu+of+adherence+support+strategies+facilitated+high+adherence+to+HIV+prevention+products+among+adolescent+girls+and+young+women+in+sub-Saharan+Africa%3A+a+mixed+methods+analysis&rft.jtitle=Journal+of+the+International+AIDS+Society&rft.au=Roberts%2C+Sarah+T&rft.au=Mancuso%2C+Noah&rft.au=Williams%2C+Kristin&rft.au=Nabunya%2C+Hadijah+Kalule&rft.date=2023-11-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=1758-2652&rft.volume=26&rft.issue=11&rft_id=info:doi/10.1002%2Fjia2.26189&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-2652&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-2652&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-2652&client=summon